Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
10.1016/S0140-6736(97)08233-0
Saved in:
Similar Items
-
Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
by: E. E. Calle, et al.
Published: (2018) -
Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
by: E. E. Calle, et al.
Published: (2018) -
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
by: Tang Y.C., et al.
Published: (2020) -
Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1
by: McPherson, J.R, et al.
Published: (2020) -
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R.A, et al.
Published: (2020)